Clinical Trials
3 trialsNCT03629717 2024-10-16
RANKL Inhibition and Breast Tissue Biomarkers
Washington University School of Medicine
Phase EARLY_PHASE1 Completed
NCT01263613 2019-11-19
Feasibility Study of Biomarkers of Response to Neoadjuvant Paclitaxel in Locally Advanced Breast Cancer
University of Wisconsin, Madison
Phase EARLY_PHASE1 Completed
NCT01329718 2014-08-04
SPR0012
Epigenomics, Inc
Phase EARLY_PHASE1 Completed